| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Shalby Limited (NSE: SHALBY)
SHALBY Technical Analysis
3
| As on 25th Apr 2024 SHALBY SHARE Price closed @ 283.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 245.64 & Buy for SHORT-TERM with Stoploss of 269.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SHALBYSHARE Price
| Open | 281.05 | Change | Price | % |
| High | 285.90 | 1 Day | 1.90 | 0.67 |
| Low | 281.05 | 1 Week | 15.90 | 5.94 |
| Close | 283.60 | 1 Month | 40.65 | 16.73 |
| Volume | 196620 | 1 Year | 140.20 | 97.77 |
| 52 Week High 257.00 | 52 Week Low 96.00 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| SHALBY Daily Charts |
SHALBY Intraday Charts |
Whats New @ Bazaartrend |
SHALBY Free Analysis |
|
|
SHALBY Important Levels Intraday
| RESISTANCE | 292.95 |
| RESISTANCE | 289.95 |
| RESISTANCE | 288.10 |
| RESISTANCE | 286.24 |
| SUPPORT | 280.96 |
| SUPPORT | 279.10 |
| SUPPORT | 277.25 |
| SUPPORT | 274.25 |
SHALBY Target April 2024
| 4th UP Target | 418.45 |
| 3rd UP Target | 369.82 |
| 2nd UP Target | 339.75 |
| 1st UP Target | 309.69 |
| 1st DOWN Target | 223.91 |
| 2nd DOWN Target | 193.85 |
| 3rd DOWN Target | 163.78 |
| 4th DOWN Target | 115.15 |
SHALBY Weekly Target
| 4th UP Target | 328.70 |
| 3rd UP Target | 308.80 |
| 2nd UP Target | 296.50 |
| 1st UP Target | 284.20 |
| 1st DOWN Target | 249.10 |
| 2nd DOWN Target | 236.80 |
| 3rd DOWN Target | 224.50 |
| 4th DOWN Target | 204.60 |
SHALBY Target2024
| 4th UP Target | 716.13 |
| 3rd UP Target | 583.51 |
| 2nd UP Target | 501.53 |
| 1st UP Target | 419.56 |
| 1st DOWN Target | 185.64 |
| 2nd DOWN Target | 103.67 |
| 3rd DOWN Target | 21.69 |
| 4th DOWN Target | -110.93 |
Shalby Limited ( NSE INDIA Symbol : SHALBY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SHALBY Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 42.70 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 67.18 | |
| 10 Day Avg Volume | Traded 25.76 % More then 10 Day Average Volume | ||
SHALBY Other Details
| Segment | EQ | |
| Market Capital | 17162787840.00 | |
| Sector | Healthcare | |
| Industry | Medical Care Facilities | |
| Offical website | > | |
SHALBY Address
 |
||
SHALBY Latest News
SHALBY Business Profile
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India. Address: Shalby Multi-Specialty Hospitals, Ahmedabad, India, 380015
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service